Tag: biosimilars billing
-
Reimbursement and Coding for Biosimilars: How Billing Works Under Medicare Part B
Biosimilars are billed differently than generics under Medicare Part B. Each has its own HCPCS code and is paid 106% of the reference product's ASP, creating financial disincentives for providers to switch. Learn how coding, payment rules, and the JZ modifier impact adoption.